|
AU716005B2
(en)
*
|
1995-06-07 |
2000-02-17 |
Cook Medical Technologies Llc |
Implantable medical device
|
|
US6774278B1
(en)
|
1995-06-07 |
2004-08-10 |
Cook Incorporated |
Coated implantable medical device
|
|
US7611533B2
(en)
*
|
1995-06-07 |
2009-11-03 |
Cook Incorporated |
Coated implantable medical device
|
|
DK1186606T4
(da)
|
1995-11-17 |
2011-12-05 |
Biotechnolog Forschung Gmbh |
Epothilonderivater, deres fremstilling og anvendelse
|
|
DK1367057T3
(da)
|
1996-11-18 |
2009-01-19 |
Biotechnolog Forschung Gmbh |
Epothiloner E og F
|
|
US20030157187A1
(en)
*
|
1996-12-02 |
2003-08-21 |
Angiotech Pharmaceuticals, Inc. |
Compositions and methods for treating or preventing inflammatory diseases
|
|
US6495579B1
(en)
|
1996-12-02 |
2002-12-17 |
Angiotech Pharmaceuticals, Inc. |
Method for treating multiple sclerosis
|
|
US6605599B1
(en)
|
1997-07-08 |
2003-08-12 |
Bristol-Myers Squibb Company |
Epothilone derivatives
|
|
US6320045B1
(en)
|
1997-12-04 |
2001-11-20 |
Bristol-Myers Squibb Company |
Process for the reduction of oxiranyl epothilones to olefinic epothilones
|
|
US6365749B1
(en)
|
1997-12-04 |
2002-04-02 |
Bristol-Myers Squibb Company |
Process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs
|
|
FR2775187B1
(fr)
|
1998-02-25 |
2003-02-21 |
Novartis Ag |
Utilisation de l'epothilone b pour la fabrication d'une preparation pharmaceutique antiproliferative et d'une composition comprenant l'epothilone b comme agent antiproliferatif in vivo
|
|
US6498257B1
(en)
|
1998-04-21 |
2002-12-24 |
Bristol-Myers Squibb Company |
2,3-olefinic epothilone derivatives
|
|
US6399638B1
(en)
|
1998-04-21 |
2002-06-04 |
Bristol-Myers Squibb Company |
12,13-modified epothilone derivatives
|
|
US6632457B1
(en)
*
|
1998-08-14 |
2003-10-14 |
Incept Llc |
Composite hydrogel drug delivery systems
|
|
US6264991B1
(en)
*
|
1998-08-18 |
2001-07-24 |
Southern Research Institute |
Compositions and methods for treating intracellular infections
|
|
US6287602B1
(en)
*
|
1998-09-16 |
2001-09-11 |
Oncopharmaceutical, Inc. |
Treatment of oncologic tumors with an injectable formulation of a Golgi apparatus disturbing agent
|
|
US6127406A
(en)
*
|
1998-10-09 |
2000-10-03 |
Harbor Branch Oceanographic Institution, Inc. |
Discodermolide compounds and methods of use
|
|
US6494879B2
(en)
|
1998-10-15 |
2002-12-17 |
Scimed Life Systems, Inc. |
Treating urinary retention
|
|
US6071952A
(en)
*
|
1998-12-02 |
2000-06-06 |
Mylan Pharmaceuticals, Inc. |
Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents
|
|
US20040234472A1
(en)
|
2001-04-20 |
2004-11-25 |
Jackson John K. |
Micellar drug delivery systems for hydrophobic drugs
|
|
US6780620B1
(en)
|
1998-12-23 |
2004-08-24 |
Bristol-Myers Squibb Company |
Microbial transformation method for the preparation of an epothilone
|
|
WO2000045868A1
(en)
*
|
1999-02-05 |
2000-08-10 |
The Regents Of The University Of California |
Thermo-reversible polymer for intralumenal implant
|
|
BR0008379A
(pt)
|
1999-02-22 |
2002-09-24 |
Biotechnolog Forschung Gmbh |
Epotilonas modificadas em c-21
|
|
US6291684B1
(en)
|
1999-03-29 |
2001-09-18 |
Bristol-Myers Squibb Company |
Process for the preparation of aziridinyl epothilones from oxiranyl epothilones
|
|
AU3957400A
(en)
|
1999-04-16 |
2000-11-02 |
Novo Nordisk A/S |
Dry, mouldable drug formulation
|
|
AU767526B2
(en)
*
|
1999-04-26 |
2003-11-13 |
Gmp Vision Solutions, Inc. |
Trabeculotomy device and method for treating glaucoma
|
|
US20040015079A1
(en)
*
|
1999-06-22 |
2004-01-22 |
Teratech Corporation |
Ultrasound probe with integrated electronics
|
|
US9402601B1
(en)
|
1999-06-22 |
2016-08-02 |
Teratech Corporation |
Methods for controlling an ultrasound imaging procedure and providing ultrasound images to an external non-ultrasound application via a network
|
|
GB9918429D0
(en)
*
|
1999-08-04 |
1999-10-06 |
Novartis Ag |
Organic compounds
|
|
TR200401209T4
(tr)
|
1999-11-05 |
2004-07-21 |
Cytovia, Inc. |
Kaspazların aktivatörleri ve apoptoz endüserleri olarak yer değiştiren 4H-kromen ve analogları ile bunların kullanımı
|
|
US7053117B2
(en)
|
2001-05-16 |
2006-05-30 |
Cytovia, Inc. |
Substituted 4H-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
|
|
JP2003525243A
(ja)
|
2000-02-28 |
2003-08-26 |
ザ ユニバーシティ オブ ブリティッシュ コロンビア |
炎症性疾患の治療のための組成物及び方法
|
|
CA2401160C
(en)
|
2000-03-01 |
2009-09-08 |
Harbor Branch Oceanographic Institution, Inc. |
Biologically active analogs of discodermolide
|
|
US6518421B1
(en)
|
2000-03-20 |
2003-02-11 |
Bristol-Myers Squibb Company |
Process for the preparation of epothilone analogs
|
|
US6593115B2
(en)
|
2000-03-24 |
2003-07-15 |
Bristol-Myers Squibb Co. |
Preparation of epothilone intermediates
|
|
DE10015479A1
(de)
*
|
2000-03-29 |
2001-10-11 |
Basf Ag |
Feste orale Darreichungsformen mit retardierter Wirkstofffreisetzung und hoher mechanischer Stabilität
|
|
US8101200B2
(en)
*
|
2000-04-13 |
2012-01-24 |
Angiotech Biocoatings, Inc. |
Targeted therapeutic agent release devices and methods of making and using the same
|
|
US6489314B1
(en)
*
|
2001-04-03 |
2002-12-03 |
Kosan Biosciences, Inc. |
Epothilone derivatives and methods for making and using the same
|
|
US20050095268A1
(en)
*
|
2000-06-12 |
2005-05-05 |
Acorn Cardiovascular, Inc. |
Cardiac wall tension relief with cell loss management
|
|
CA2410632A1
(en)
|
2000-06-22 |
2001-12-27 |
David S. Garvey |
Nitrosated and nitrosylated taxanes, compositions and methods of use
|
|
UA75365C2
(en)
*
|
2000-08-16 |
2006-04-17 |
Bristol Myers Squibb Co |
Epothilone analog polymorph modifications, a method for obtaining thereof (variants), a pharmaceutical composition based thereon
|
|
KR20090089922A
(ko)
|
2000-10-18 |
2009-08-24 |
파마셋 인코포레이티드 |
바이러스 감염 및 비정상적인 세포 증식의 치료를 위한 변형된 뉴클레오시드
|
|
JP2002154963A
(ja)
*
|
2000-11-14 |
2002-05-28 |
Yakult Honsha Co Ltd |
徐放性抗腫瘍剤
|
|
IL156580A0
(en)
|
2001-01-25 |
2004-01-04 |
Bristol Myers Squibb Co |
A method for formulating an epothilone analog for parenteral use and pharmaceutical preparations including an epothilone analog
|
|
HU229349B1
(en)
|
2001-01-25 |
2013-11-28 |
Bristol Myers Squibb Co |
Methods for preparation of pharmaceutical composition containing epothilone analogs useful for treatment of cancer
|
|
NZ526871A
(en)
|
2001-01-25 |
2006-01-27 |
Bristol Myers Squibb Co |
Pharmaceutical dosage forms of epothilones for oral administration
|
|
US6893859B2
(en)
|
2001-02-13 |
2005-05-17 |
Kosan Biosciences, Inc. |
Epothilone derivatives and methods for making and using the same
|
|
BR0207487A
(pt)
|
2001-02-20 |
2004-08-10 |
Brystol Myers Squibb Company |
Método de tratamento de tumores em mamìferos e uso de compostos de epotilona
|
|
PL363363A1
(en)
|
2001-02-20 |
2004-11-15 |
Bristol-Myers Squibb Company |
Epothilone derivatives for the treatment of refractory tumors
|
|
WO2002072150A2
(en)
*
|
2001-03-13 |
2002-09-19 |
Angiotech Pharmaceuticals Inc. |
Micellar drug delivery vehicles and uses thereof
|
|
WO2002072085A1
(en)
|
2001-03-14 |
2002-09-19 |
Bristol-Myers Squibb Company |
Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases
|
|
US7771468B2
(en)
*
|
2001-03-16 |
2010-08-10 |
Angiotech Biocoatings Corp. |
Medicated stent having multi-layer polymer coating
|
|
SK287334B6
(sk)
*
|
2001-03-19 |
2010-07-07 |
Novartis Ag |
Kombinácia protihnačkového činidla a epotilónu alebo jeho derivátu, farmaceutická kompozícia a obchodné balenie, ktoré ju obsahujú, a jej použitie
|
|
DE10115740A1
(de)
*
|
2001-03-26 |
2002-10-02 |
Ulrich Speck |
Zubereitung für die Restenoseprophylaxe
|
|
US20020192280A1
(en)
*
|
2001-05-01 |
2002-12-19 |
Angiotech Pharmaceuticals, Inc. |
Compositions and methods for treating inflammatory conditions utilizing protein or polysaccharide containing anti-microtubule agents
|
|
US20030157161A1
(en)
*
|
2001-05-01 |
2003-08-21 |
Angiotech Pharmaceuticals, Inc. |
Compositions and methods for treating inflammatory conditions utilizing protein or polysaccharide containing anti-microtubule agents
|
|
US6858607B1
(en)
|
2001-05-16 |
2005-02-22 |
Cytovia, Inc. |
7,8-fused 4H-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof
|
|
MXPA03010909A
(es)
|
2001-06-01 |
2004-02-17 |
Bristol Myers Squibb Co |
Derivados de epotilona.
|
|
IL145751A
(en)
*
|
2001-10-04 |
2010-12-30 |
Avi Dascalu |
Use of aluminum fluoride for the preparation of compositions for the treatment of acne vulgaris and folliculitis
|
|
US7582670B2
(en)
*
|
2001-12-13 |
2009-09-01 |
Natrogen Therapeutics, Inc. |
Methods of treating an inflammatory-related disease
|
|
US8454997B2
(en)
|
2001-12-18 |
2013-06-04 |
Novo Nordisk A/S |
Solid dose micro implant
|
|
CA2470826A1
(en)
*
|
2001-12-20 |
2003-07-03 |
Bristol-Myers Squibb Company |
Pharmaceutical compositions of orally active taxane derivatives having enhanced bioavailability
|
|
US20030194421A1
(en)
*
|
2001-12-28 |
2003-10-16 |
Angiotech Pharmaceuticals, Inc. |
Treatment of uveitis
|
|
EP1340498A1
(en)
*
|
2002-03-01 |
2003-09-03 |
Schering Aktiengesellschaft |
Use of epothilones in the treatment of brain diseases associated with proliferative processes
|
|
EP1485090B1
(en)
*
|
2002-03-08 |
2007-10-10 |
Novartis AG |
Combinations comprising an epothilone derivative and an imidazotetrazinone
|
|
AU2003224672B2
(en)
|
2002-03-08 |
2010-02-04 |
Eisai R&D Management Co., Ltd. |
Macrocyclic compounds useful as pharmaceuticals
|
|
SI1483251T1
(sl)
|
2002-03-12 |
2010-03-31 |
Bristol Myers Squibb Co |
C cian epotilonski derivati
|
|
AU2003218107A1
(en)
|
2002-03-12 |
2003-09-29 |
Bristol-Myers Squibb Company |
C12-cyano epothilone derivatives
|
|
AU2003228354B8
(en)
|
2002-03-22 |
2010-03-04 |
Eisai R&D Management Co., Ltd. |
Hemiasterlin derivatives and uses thereof in the treatment of cancer
|
|
TW200403994A
(en)
|
2002-04-04 |
2004-03-16 |
Bristol Myers Squibb Co |
Oral administration of EPOTHILONES
|
|
TW200400191A
(en)
|
2002-05-15 |
2004-01-01 |
Bristol Myers Squibb Co |
Pharmaceutical compositions and methods of using C-21 modified epothilone derivatives
|
|
AU2003230411A1
(en)
|
2002-05-16 |
2003-12-02 |
Cytovia, Inc. |
Substituted 4-aryl-4h-pyrrolo(2,3-h)chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
|
|
US7476741B2
(en)
|
2002-05-16 |
2009-01-13 |
Cytovia, Inc. |
Substituted 4H-chromens, 2H-chromenes, chromans and analogs as activators of caspases and inducers of apoptosis and the use thereof
|
|
WO2003105828A1
(en)
|
2002-06-14 |
2003-12-24 |
Bristol-Myers Squibb Company |
Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases
|
|
DK1521603T3
(da)
*
|
2002-07-12 |
2011-04-18 |
Cook Inc |
Coated medicinsk anordning
|
|
DE10244847A1
(de)
|
2002-09-20 |
2004-04-01 |
Ulrich Prof. Dr. Speck |
Medizinische Vorrichtung zur Arzneimittelabgabe
|
|
BRPI0314133A8
(pt)
|
2002-09-23 |
2017-09-19 |
Bristol Myers Squibb Co |
Processo para isolamento de epotilona b, métodos para cultivo de microorganismo que produza epotilona a ou b e para purifiação de apotilona
|
|
KR20050084599A
(ko)
*
|
2002-09-26 |
2005-08-26 |
안지오테크 인터내셔날 아게 |
혈관주위 랩
|
|
US7544932B2
(en)
*
|
2002-10-21 |
2009-06-09 |
The United States Of America, As Represented By The Secretary, Of The Department Of Health And Human Services |
Contiguous capillary electrospray sources and analytical devices
|
|
WO2004052361A1
(en)
*
|
2002-12-09 |
2004-06-24 |
Novartis Ag |
Microtubule stabilisers for treating stenosis in stents
|
|
JP2006520786A
(ja)
|
2003-03-14 |
2006-09-14 |
シネクサス， インコーポレイテッド |
徐放性治療剤の洞送達
|
|
US6989370B2
(en)
*
|
2003-05-01 |
2006-01-24 |
The United States Of America As Represented By The Secretary Of Agriculture |
Bacteriocins and novel bacterial strains
|
|
US7229979B2
(en)
*
|
2003-06-23 |
2007-06-12 |
Immune Modulation, Inc. |
Hypoestoxides, derivatives and agonists thereof for use as stent-coating agents
|
|
WO2005007129A2
(en)
*
|
2003-07-17 |
2005-01-27 |
Angiotech International Ag |
Topical formulations with bioactive components
|
|
US20050095283A1
(en)
*
|
2003-09-16 |
2005-05-05 |
Aphios Corporation |
Compositions and methods for topically treating diseases
|
|
WO2005049105A2
(en)
*
|
2003-11-10 |
2005-06-02 |
Angiotech International Ag |
Medical implants and anti-scarring agents
|
|
US20050208095A1
(en)
*
|
2003-11-20 |
2005-09-22 |
Angiotech International Ag |
Polymer compositions and methods for their use
|
|
CA2536192A1
(en)
*
|
2003-11-20 |
2005-06-09 |
Angiotech International Ag |
Soft tissue implants and anti-scarring agents
|
|
US7959659B2
(en)
|
2004-01-02 |
2011-06-14 |
Advanced Cardiovascular Systems, Inc. |
High-density lipoprotein coated medical devices
|
|
CA2536096A1
(en)
*
|
2004-01-30 |
2005-08-18 |
Angiotech International Ag |
Compositions and methods for treating contracture
|
|
EP1559447A1
(en)
*
|
2004-01-30 |
2005-08-03 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Use of epothilones in the treatment of neuronal connectivity defects such as schizophrenia and autism
|
|
US20060211752A1
(en)
|
2004-03-16 |
2006-09-21 |
Kohn Leonard D |
Use of phenylmethimazoles, methimazole derivatives, and tautomeric cyclic thiones for the treatment of autoimmune/inflammatory diseases associated with toll-like receptor overexpression
|
|
WO2005089800A1
(ja)
*
|
2004-03-17 |
2005-09-29 |
Locomogene, Inc. |
hsHRD3を含む医薬組成物
|
|
US8003122B2
(en)
*
|
2004-03-31 |
2011-08-23 |
Cordis Corporation |
Device for local and/or regional delivery employing liquid formulations of therapeutic agents
|
|
US7989490B2
(en)
*
|
2004-06-02 |
2011-08-02 |
Cordis Corporation |
Injectable formulations of taxanes for cad treatment
|
|
KR20070036062A
(ko)
*
|
2004-05-07 |
2007-04-02 |
펩팀문, 인코포레이티드 |
랜덤 공중합체에 의해 질병을 치료하는 방법
|
|
US20050266043A1
(en)
*
|
2004-05-27 |
2005-12-01 |
Medtronic Vascular, Inc. |
Methods and compounds for treatment of aneurysmal tissue
|
|
US20080124400A1
(en)
*
|
2004-06-24 |
2008-05-29 |
Angiotech International Ag |
Microparticles With High Loadings Of A Bioactive Agent
|
|
US20060142198A1
(en)
*
|
2004-07-02 |
2006-06-29 |
Wound Care Partners Llc |
Compositions for treating wounds and processes for their preparation
|
|
US8119153B2
(en)
*
|
2004-08-26 |
2012-02-21 |
Boston Scientific Scimed, Inc. |
Stents with drug eluting coatings
|
|
RU2282454C2
(ru)
*
|
2004-10-25 |
2006-08-27 |
Ильдар Фанусович Суфияров |
Средство для лечения послеоперационных спаек в органах брюшной полости
|
|
US20100093767A1
(en)
*
|
2004-12-03 |
2010-04-15 |
Takeda San Diego, Inc. |
Mitotic Kinase Inhibitors
|
|
USH2260H1
(en)
|
2005-02-17 |
2011-07-05 |
Angiotech International Ag |
Stents combined with paclitaxel derivatives
|
|
EP1700596A1
(en)
*
|
2005-03-09 |
2006-09-13 |
Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E.V. |
Use of microtubule stabilizing compounds for the treatment of lesions of CNS axons
|
|
MX2007011218A
(es)
*
|
2005-03-23 |
2007-10-17 |
Biosafe Sa |
Sistema integrado para colectar, procesar y transplantar subconjuntos de celulas, incluyendo celulas madre adultas para medicina regenerativa.
|
|
US20060222627A1
(en)
*
|
2005-03-30 |
2006-10-05 |
Andrew Carter |
Optimizing pharmacodynamics of therapeutic agents for treating vascular tissue
|
|
CA2603081C
(en)
|
2005-04-04 |
2013-09-03 |
Sinexus, Inc. |
Device and methods for treating paranasal sinus conditions
|
|
US20060224095A1
(en)
*
|
2005-04-05 |
2006-10-05 |
University Of New Hampshire |
Biocompatible polymeric vesicles self assembled from triblock copolymers
|
|
US8002738B2
(en)
*
|
2005-05-17 |
2011-08-23 |
Boston Scientific Scimed, Inc. |
Self-adhering lesion formation apparatus and methods
|
|
ES2462541T3
(es)
*
|
2005-06-09 |
2014-05-23 |
Meda Ab |
Método y composición para el tratamiento de trastornos inflamatorios
|
|
ITMI20051826A1
(it)
*
|
2005-09-29 |
2007-03-30 |
Novachem S A |
Kit per la somministrazione parenterale di medicamenti
|
|
NZ567286A
(en)
*
|
2005-11-01 |
2012-03-30 |
Abbott Biotechnolgy Ltd |
Methods and compositions for diagnosing ankylosing spondylitis using biomarkers
|
|
US20070196423A1
(en)
*
|
2005-11-21 |
2007-08-23 |
Med Institute, Inc. |
Implantable medical device coatings with biodegradable elastomer and releasable therapeutic agent
|
|
RU2309768C2
(ru)
*
|
2005-12-21 |
2007-11-10 |
Федеральное государственное унитарное предприятие "Научно-исследовательский институт синтетического волокна с экспериментальным заводом" (ФГУП "ВНИИСВ") |
Шовный хирургический материал (варианты)
|
|
CU23388B6
(es)
*
|
2006-01-31 |
2009-07-16 |
Ct Ingenieria Genetica Biotech |
Composición farmacéutica de microesferas para prevenir la amputación del pie diabético
|
|
ES2579762T3
(es)
*
|
2006-03-01 |
2016-08-16 |
Janssen Pharmaceutica N.V. |
Tratamiento del cáncer combinando agente linfo - reductor con CLTs y citoquinas
|
|
US20070275035A1
(en)
*
|
2006-05-24 |
2007-11-29 |
Microchips, Inc. |
Minimally Invasive Medical Implant Devices for Controlled Drug Delivery
|
|
RU2311171C1
(ru)
*
|
2006-05-29 |
2007-11-27 |
Автономная некоммерческая организация Научно-технический центр "Фармбиопресс" |
Противоинфекционный липосомный препарат и фармацевтическая композиция на его основе
|
|
US9173773B2
(en)
*
|
2006-06-21 |
2015-11-03 |
Johnson & Johnson Vision Care, Inc. |
Punctal plugs for the delivery of active agents
|
|
US8066824B2
(en)
*
|
2006-07-07 |
2011-11-29 |
Intezyne Technologies, Inc. |
Covalent modification of metal surfaces
|
|
WO2008013966A2
(en)
*
|
2006-07-28 |
2008-01-31 |
Johns Hopkins University |
Use of 8-quinolinol and its analogs to target cancer stem cells
|
|
US20080085293A1
(en)
*
|
2006-08-22 |
2008-04-10 |
Jenchen Yang |
Drug eluting stent and therapeutic methods using c-Jun N-terminal kinase inhibitor
|
|
US20080051702A1
(en)
*
|
2006-08-24 |
2008-02-28 |
Herrmann Robert A |
Therapeutic agent delivery for the treatment of asthma via implantable and insertable medical devices
|
|
DE102006049185A1
(de)
*
|
2006-10-18 |
2008-04-24 |
Bayerl, Thomas M., Prof. Dr. |
Verwendung von Deuteriumdioxid zur Behandlung von hyperproliferativen Erkrankungen der Haut
|
|
WO2008076383A2
(en)
*
|
2006-12-18 |
2008-06-26 |
Med Institute Inc. |
Stent graft with releasable therapeutic agent
|
|
RU2338539C2
(ru)
*
|
2006-12-18 |
2008-11-20 |
Наталья Александровна Уракова |
Способ медикаментозной индукции родов
|
|
EP1964560A1
(en)
*
|
2007-02-28 |
2008-09-03 |
Helmholtz-Zentrum für Infektionsforschung GmbH |
Use of inhibitors of the degradation of p27 for the treatment of cancer
|
|
ES2310122B1
(es)
*
|
2007-04-20 |
2009-10-30 |
Instituto Cientifico Y Tecnologico De Navarra, S.A |
Nanoparticulas que comprenden una ciclodextrina y una molecula biologicamente activa y sus aplicaciones.
|
|
RU2333492C1
(ru)
*
|
2007-04-23 |
2008-09-10 |
Государственное образовательное учреждение высшего профессионального образования "Оренбургская государственная медицинская академия" Федерального агентства по здравоохранению и социальному развитию (ГОУ ВПО ОрГМА Росздрава) |
Способ прогнозирования циклохориоидальной отслойки после антиглаукоматозных операций
|
|
ITMI20071267A1
(it)
*
|
2007-06-22 |
2008-12-23 |
Fidia Farmaceutici |
Uso di coniugati dell'acido ialuronico nel trattamento locale di malattie cutanee iperproliferative
|
|
DE102007031397A1
(de)
|
2007-07-05 |
2009-01-08 |
D2O Bioscience Group Ltd. |
Verwendung von Deuteriumoxid zur Behandlung von Virus-basierten Erkrankungen der Haut
|
|
SI2170287T1
(sl)
*
|
2007-07-26 |
2014-04-30 |
Aqtis Ip Bv |
Mikrodelci, ki vsebujejo pcl in njihova uporaba
|
|
EP2050814A1
(en)
*
|
2007-10-17 |
2009-04-22 |
Txcell |
Compositions for treating multiple sclerosis
|
|
RU2381027C2
(ru)
*
|
2007-12-13 |
2010-02-10 |
Михаил Владимирович Кутушов |
Применение фунгицида беномил в качестве средства для лечения онкологических заболеваний
|
|
PT2231065T
(pt)
*
|
2007-12-18 |
2020-12-07 |
Intersect Ent Inc |
Dispositivos autoexpansíveis
|
|
RU2356053C1
(ru)
*
|
2008-02-29 |
2009-05-20 |
Государственное образовательное учреждение высшего профессионального образования "Пермская государственная медицинская академия имени академика Е.А. Вагнера Федерального агентства по здравоохранению и социальному развитию" |
Способ дифференциальной диагностики инфекционно-воспалительных осложнений при травме глаза
|
|
US8420110B2
(en)
*
|
2008-03-31 |
2013-04-16 |
Cordis Corporation |
Drug coated expandable devices
|
|
US8409601B2
(en)
*
|
2008-03-31 |
2013-04-02 |
Cordis Corporation |
Rapamycin coated expandable devices
|
|
KR101100867B1
(ko)
*
|
2008-05-14 |
2012-01-02 |
주식회사 운화 |
주목의 형성층 또는 전형성층 유래 식물줄기세포주를 유효성분으로 함유하는 항산화, 항염증 또는 항노화용 조성물
|
|
US8642063B2
(en)
*
|
2008-08-22 |
2014-02-04 |
Cook Medical Technologies Llc |
Implantable medical device coatings with biodegradable elastomer and releasable taxane agent
|
|
EP2946770A1
(en)
*
|
2008-08-29 |
2015-11-25 |
Genzyme Corporation |
Controlled-released peptide formulations
|
|
DE102009003992A1
(de)
*
|
2009-01-07 |
2010-07-08 |
D2O Biosience Group Ltd., Hamilton |
Verwendung von Deuteriumoxid zur Behandlung Virus-basierter Erkrankungen des Respirationstraktes
|
|
DE102009003942A1
(de)
|
2009-01-07 |
2010-07-08 |
D2O Biosience Group Ltd., Hamilton |
Verwendung von Deuteriumoxid zur Behandlung Virus-basierter Erkrankungen des Auges
|
|
US20110306565A1
(en)
*
|
2009-01-13 |
2011-12-15 |
Margit Mahlapuu |
Hyaluronic acid containing compositions for treatment of wounds, scars, post-surgical adhesion formation
|
|
DE102009011931A1
(de)
|
2009-03-10 |
2010-09-16 |
Innora Gmbh |
Vorrichtung zur Applikation von Wirkstoffen auf die Wand eines Körpergefäßes
|
|
US10206813B2
(en)
|
2009-05-18 |
2019-02-19 |
Dose Medical Corporation |
Implants with controlled drug delivery features and methods of using same
|
|
US12478503B2
(en)
|
2009-05-18 |
2025-11-25 |
Glaukos Corporation |
Implants with controlled drug delivery features and methods of using same
|
|
US20110021869A1
(en)
*
|
2009-07-24 |
2011-01-27 |
Hilary John Cholhan |
Single-incision minimally-invasive surgical repair of pelvic organ/vaginal prolapse conditions
|
|
GB0917817D0
(en)
|
2009-10-12 |
2009-11-25 |
Biotica Tech Ltd |
Novel compounds and methods for their production
|
|
GB0917816D0
(en)
|
2009-10-12 |
2009-11-25 |
Biotica Tech Ltd |
Novel compounds and methods for their production
|
|
WO2011072398A1
(en)
|
2009-12-18 |
2011-06-23 |
Interface Biologics, Inc. |
Local delivery of drugs from self assembled coatings
|
|
US8858577B2
(en)
|
2010-05-19 |
2014-10-14 |
University Of Utah Research Foundation |
Tissue stabilization system
|
|
US8945156B2
(en)
|
2010-05-19 |
2015-02-03 |
University Of Utah Research Foundation |
Tissue fixation
|
|
US8852214B2
(en)
|
2011-02-04 |
2014-10-07 |
University Of Utah Research Foundation |
System for tissue fixation to bone
|
|
RU2451680C1
(ru)
|
2011-02-21 |
2012-05-27 |
Общество С Ограниченной Ответственностью "Научно-Исследовательская Компания "Медбиофарм" |
Клатратный комплекс циклодекстрина или арабиногалактана с 9-фенил-симм-октагидроселеноксантеном, способ его получения (варианты), фармацевтическая композиция и лекарственное средство
|
|
US20120315303A1
(en)
*
|
2011-05-05 |
2012-12-13 |
Medtronic Vascular, Inc. |
Methods and intravascular treatment devices using paclitaxel for treatment of atherosclerosis
|
|
US20140286908A1
(en)
*
|
2011-10-18 |
2014-09-25 |
Nestec S.A. |
Composition for use in the promotion of intestinal angiogenesis and of nutrient absorption and of enteral feeding tolerance and/or in the prevention and/or treatment of intestinal inflammation and/or in the recovery after intestinal injury and surgery
|
|
US9220759B2
(en)
|
2012-02-23 |
2015-12-29 |
Abbott Cardiovascular Systems Inc. |
Treatment of diabetic patients with a drug eluting stent and adjunctive therapy
|
|
US9220584B2
(en)
|
2012-03-30 |
2015-12-29 |
Abbott Cardiovascular Systems Inc. |
Treatment of diabetic patients with a stent and locally administered adjunctive therapy
|
|
US11957334B2
(en)
|
2012-07-30 |
2024-04-16 |
Conextions, Inc. |
Devices, systems, and methods for repairing soft tissue and attaching soft tissue to bone
|
|
US10835241B2
(en)
|
2012-07-30 |
2020-11-17 |
Conextions, Inc. |
Devices, systems, and methods for repairing soft tissue and attaching soft tissue to bone
|
|
US9427309B2
(en)
|
2012-07-30 |
2016-08-30 |
Conextions, Inc. |
Soft tissue repair devices, systems, and methods
|
|
US10219804B2
(en)
|
2012-07-30 |
2019-03-05 |
Conextions, Inc. |
Devices, systems, and methods for repairing soft tissue and attaching soft tissue to bone
|
|
US10390935B2
(en)
|
2012-07-30 |
2019-08-27 |
Conextions, Inc. |
Soft tissue to bone repair devices, systems, and methods
|
|
US11253252B2
(en)
|
2012-07-30 |
2022-02-22 |
Conextions, Inc. |
Devices, systems, and methods for repairing soft tissue and attaching soft tissue to bone
|
|
US11944531B2
(en)
|
2012-07-30 |
2024-04-02 |
Conextions, Inc. |
Devices, systems, and methods for repairing soft tissue and attaching soft tissue to bone
|
|
JP6595454B2
(ja)
*
|
2013-05-03 |
2019-10-23 |
リピドール エービー |
薬学的又は化粧学的活性成分を投与するための局部用組成物及びキャリアー
|
|
RU2525181C1
(ru)
*
|
2013-07-26 |
2014-08-10 |
Федеральное государственное бюджетное учреждение "Научно-исследовательский институт комплексных проблем сердечно-сосудистых заболеваний" Сибирского отделения Российской академии медицинских наук (ФГБУ "НИИ КПССЗ" СО РАМН) |
Способ изготовления биодеградируемых мембран для предотвращения образования спаек после кардиохирургических операций
|
|
US11583384B2
(en)
|
2014-03-12 |
2023-02-21 |
Conextions, Inc. |
Devices, systems, and methods for repairing soft tissue and attaching soft tissue to bone
|
|
WO2015138760A1
(en)
|
2014-03-12 |
2015-09-17 |
Conextions, Inc. |
Soft tissue repair devices, systems, and methods
|
|
US12508019B2
(en)
|
2014-03-12 |
2025-12-30 |
Conextions, Inc. |
Devices, systems, and methods for repairing soft tissue and attaching soft tissue to bone
|
|
KR102348707B1
(ko)
*
|
2014-08-12 |
2022-01-06 |
주식회사 엘지생활건강 |
도세탁셀 또는 이의 약학적으로 허용가능한 염을 포함하는 피부 탄력, 주름개선, 보습 또는 항염증용 화장료 또는 약학 조성물
|
|
KR102263764B1
(ko)
*
|
2014-08-13 |
2021-06-09 |
주식회사 엘지생활건강 |
세팔로만닌 또는 이의 약학적으로 허용가능한 염을 포함하는 피부 미백 또는 항염증용 화장료 또는 약학 조성물
|
|
CN104546931B
(zh)
*
|
2014-09-30 |
2019-04-09 |
深圳华大基因科技有限公司 |
华德萨特氏菌在治疗或预防类风湿性关节炎或其相关疾病中的应用
|
|
US9855317B2
(en)
|
2015-04-27 |
2018-01-02 |
Reflex Medical, Inc. |
Systems and methods for sympathetic cardiopulmonary neuromodulation
|
|
CR20180128A
(es)
*
|
2015-08-05 |
2018-04-24 |
Childrens Medical Center |
Composiciones con potenciadores de permeación para suministro de fármacos
|
|
CA2998483C
(en)
*
|
2015-09-16 |
2022-09-06 |
Dfb Soria, Llc |
Delivery of drug nanoparticles and methods of use thereof
|
|
US11246879B2
(en)
|
2016-02-09 |
2022-02-15 |
Tulai Therapeutics, Inc. |
Methods, agents, and devices for local neuromodulation of autonomic nerves
|
|
KR20180000682A
(ko)
*
|
2016-06-22 |
2018-01-03 |
서울대학교산학협력단 |
5-(3',4'-디히드록시페닐)-감마-발레로락톤을 함유하는 동맥경화 개선용 식품 조성물 및 동맥경화 예방 및 치료용 약학 조성물
|
|
US11154547B2
(en)
|
2016-06-29 |
2021-10-26 |
Tulavi Therapeutics, Inc. |
Treatment of sepsis and related inflammatory conditions by local neuromodulation of the autonomic nervous system
|
|
US11696822B2
(en)
|
2016-09-28 |
2023-07-11 |
Conextions, Inc. |
Devices, systems, and methods for repairing soft tissue and attaching soft tissue to bone
|
|
WO2018170196A1
(en)
|
2017-03-15 |
2018-09-20 |
Dfb Soria, Llc |
Topical therapy for the treatment of skin malignancies using nanoparticles of taxanes
|
|
MX2019012086A
(es)
*
|
2017-04-14 |
2021-01-08 |
Gelesis Llc |
Composiciones y métodos para tratar o prevenir trastornos relacionados con la permeabilidad intestinal.
|
|
CN106943380B
(zh)
*
|
2017-05-17 |
2021-02-05 |
杜楠 |
Vegf单抗联合纳米紫杉醇在制备治疗癌性腹腔粘连药物中的应用
|
|
US11547397B2
(en)
|
2017-12-20 |
2023-01-10 |
Conextions, Inc. |
Devices, systems, and methods for repairing soft tissue and attaching soft tissue to bone
|
|
US12102317B2
(en)
|
2017-12-20 |
2024-10-01 |
Conextions, Inc. |
Devices, systems, and methods for repairing soft tissue and attaching soft tissue to bone
|
|
CN118303936A
(zh)
|
2018-02-20 |
2024-07-09 |
科内克思申斯股份有限公司 |
用于将软组织固定到骨的医疗装置系统
|
|
US10974022B2
(en)
*
|
2018-02-28 |
2021-04-13 |
Gyrus Acmi, Inc. |
Nasal implant assembly
|
|
US11497726B2
(en)
|
2018-03-16 |
2022-11-15 |
Dfb Soria, Ll. |
Topical therapy for the treatment of cervical intraepithelial neoplasia (CIN) and cervical cancer using nanoparticles of taxanes
|
|
WO2019217536A1
(en)
*
|
2018-05-08 |
2019-11-14 |
University Of Connecticut |
Long-acting local anesthetic formulation
|
|
EP3796948A4
(en)
|
2018-05-22 |
2022-03-02 |
Interface Biologics Inc. |
COMPOSITIONS AND METHODS FOR ADMINISTRATION OF MEDICATIONS TO A VESSEL WALL
|
|
US11648197B2
(en)
|
2018-06-28 |
2023-05-16 |
Arx, Llc |
Dispensing method for producing dissolvable unit dose film constructs
|
|
US20210315587A1
(en)
|
2018-07-02 |
2021-10-14 |
Tulavi Therapeutics, Inc. |
Methods and devices for in situ formed nerve cap with rapid release
|
|
CN117598837A
(zh)
|
2018-07-02 |
2024-02-27 |
图拉维治疗股份有限公司 |
原位形成神经帽的方法和装置
|
|
RU2703257C1
(ru)
*
|
2018-12-04 |
2019-10-16 |
Закрытое акционерное общество "СКАЙ ЛТД" |
Способ лечения воспалительных процессов суставов и простатита
|
|
ES2947713T3
(es)
|
2019-06-13 |
2023-08-17 |
Hollister Inc |
Productos de catéter urinario reutilizables
|
|
WO2020263859A1
(en)
|
2019-06-25 |
2020-12-30 |
Hollister Incorporated |
Reusable urinary catheter products
|
|
CN110420072B
(zh)
*
|
2019-07-24 |
2024-01-23 |
莆田学院 |
一种应用于机能学的大鼠灌胃装置
|
|
EP4017474A1
(en)
*
|
2019-08-21 |
2022-06-29 |
Timber Pharmaceuticals, Inc. |
Solvent delivery system for topical delivery of active agents
|
|
WO2022074649A1
(en)
*
|
2020-10-05 |
2022-04-14 |
Ichilov Tech Ltd. |
Treatment of skin diseases
|
|
CN117982720B
(zh)
*
|
2024-04-01 |
2024-06-04 |
成都中医药大学 |
一种预防损伤放松肌肉的中药材凝胶敷料及其制备方法
|